GB664262A - Manufacture of heterocyclically substituted diaminoquinazolines - Google Patents

Manufacture of heterocyclically substituted diaminoquinazolines

Info

Publication number
GB664262A
GB664262A GB3339/49A GB333949A GB664262A GB 664262 A GB664262 A GB 664262A GB 3339/49 A GB3339/49 A GB 3339/49A GB 333949 A GB333949 A GB 333949A GB 664262 A GB664262 A GB 664262A
Authority
GB
United Kingdom
Prior art keywords
amino
diethylamino
quinazoline
benzthiazole
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3339/49A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB664262A publication Critical patent/GB664262A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Heterocyclically - disubstituted quinazolines are prepared by treating a quinazoline having in the 2- or 4-position a halogen atom or a substituted hydroxy or mercapto group and in the other of these positions a substituted amino group wherein the substituent contains a tertiary amino group, with an amino compound, the amino group of which is directly bound to the carbon atom in the 2-position of a thiazole or imidazole ring; alternatively, the same products may be obtained by reacting an amino-substituted tertiary amine with the appropriate thiazoylamino- or imidazolylaminoquinazoline. The thiazole or imidazole ring may be present in the form of benzthiazole or benzimidazole and in general may have fusedon aromatic or heterocyclic nuclei. The products may contain alkyl, phenyl, nitro, amino, cyano, halogen or free or substituted hydroxyl substituents. The residue containing a tertiary amino group may be a straight or branched aliphatic residue (with or without interrupting heteroatoms such as oxygen and sulphur) or a carboxylic or aliphatic-carbocyclic residue containing as substituent a dialkylamino group, or a chain terminated by a cyclic group such as piperidino or morpholino. The reaction may be carried out in the presence or absence of a diluent, an acid-binding agent, a condensing agent or a catalyst. The products (if obtained as free bases) may be converted into salts with acids such as hydrochloric, sulphuric, phosphoric, methane sulphonic, toluene sulphonic, acetic, oxalic and citric acids. Nitro groups in the products may be reduced to amino groups. Many examples are given, the residues being those of (1) quinoxaline and 6 - chloro - quinoxaline; (2) 2 - amino - benzthiazole, 2 - amino - 4 - methyl - benzthiazole, 2 - amino - 6 - methyl - benzthiazole, 2 - amino - 6 - chloro - benzthiazole, 2 - amino - 6 - methoxy - benzthiazole, 2 - amino - 4 : 7 - dimethyl - benzthiazole, 2 - amino - 6 - nitro - benzthiazole, 2 - amino - 6 - cyano - benzthiazole, 2 - amino - 6 - n - butoxy - benzthiazole, 2 - amino - 6 - acetamino - benzthiazole, 2 - amino - naphthothiazole, 2-amino-thiazole, 2-amino-4-phenylthiazole, 2 - amino - 4 - p - bromophenyl - thiazole, 2 - amino - 4 : 5 - diphenyl - thiazole and 2 - amino - benzimidazole; (3) b - diethylamino - ethylamine, g - diethylamino - propylamine, N - (b - diethylamino - ethyl) - aniline, 1 - diethylamino - 3 - amino - butane, b - piperidino - ethylamine and p - (b - diethylamino - ethoxy)-aniline. The starting materials are obtained by reacting a quinazoline substituted in the 2- and 4-positions by exchangeable groups (e.g. 2 : 4-dichloroquinazoline, 2-chloro-4-hydroxy-quinazoline) with the appropriate amine. Compounds thus prepared are 2-chloro-4-[N-phenyl-N - (b - diethylamino - ethyl) - amino - ] quinazoline, 2 - [61 - methyl - benzthiazolyl - 21 - amino] - 4 - hydroxy - quinazoline (converted into the 4-chloro-compound with phosphorus oxychloride), 2-(b -diethylamino-ethylamino)-4-hydroxy-quinazoline (converted into the 4-chloro-compound with phosphorus oxychloride), 2 - chloro - 4 - [p - (b - diethylamino - ethoxy) - anilino] - quinazoline and 2 - chloro - 4 - [11 - diethylamino - butyl - 31 - amino] - quinazoline. 2 - Amino - 4 : 7 - dimethyl - benzthiazole is obtained from 2 : 5-dimethyl-phenyl-thiourea by normal methods. 2 - Methoxy - 4 - (b - diethylamino - ethylamino)-quinazoline is obtained from the 2-chloro-compound and sodium methoxide. Samples have been furnished under Sect. 2 (5) of (1) 2-[41-p-tolyl-thiazolyl-21-amino]-4-(b -diethylamino -ethylamino)-quinazoline prepared from 2 - amino - 4 - p - tolyl - thiazole and 2 - chloro - 4 - (b - diethylamino - ethylamino) - quinazoline; and (2) 2-[61-methyl-benzthiazolyl-21 - amino] - 4 - [b - (b 1 - diethylamino - ethylthio) - ethylamino] - quinazoline prepared by reacting 2 : 4-dichloro-quinazoline with b -amino-b 1 - diethylamino - diethyl sulphide and treating the resulting 2-chloro-4-[b -(b 1-diethylaminoethylthio) - ethylamino] - quinazoline with 2 - amino-6-methyl-benzthiazole. The Specification as open to inspection under Sect. 91 refers to compounds containing in place of the tertiary amino group any strongly basic group, e.g. primary or secondary amino. It also mentions compounds containing mercapto substituents. The attachment to the thiazole or imidazole ring is not limited to the 2-position. This subject-matter does not appear in the Specification as accepted.
GB3339/49A 1948-02-09 1949-02-07 Manufacture of heterocyclically substituted diaminoquinazolines Expired GB664262A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH664262X 1948-02-09

Publications (1)

Publication Number Publication Date
GB664262A true GB664262A (en) 1952-01-02

Family

ID=4527159

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3339/49A Expired GB664262A (en) 1948-02-09 1949-02-07 Manufacture of heterocyclically substituted diaminoquinazolines

Country Status (5)

Country Link
BE (1) BE487239A (en)
CH (3) CH276269A (en)
FR (1) FR980225A (en)
GB (1) GB664262A (en)
NL (1) NL70218C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1404337A2 (en) * 2001-06-19 2004-04-07 Bristol-Myers Squibb Company QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1404337A2 (en) * 2001-06-19 2004-04-07 Bristol-Myers Squibb Company QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
EP1404337A4 (en) * 2001-06-19 2006-04-12 Bristol Myers Squibb Co QUINAZOLINE AND PYRIDO 2,3-d|PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
US7601836B2 (en) 2001-06-19 2009-10-13 Bristol-Myers Squibb Company Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

Also Published As

Publication number Publication date
FR980225A (en) 1951-05-09
CH276269A (en) 1951-06-30
NL70218C (en)
BE487239A (en)
CH279190A (en) 1951-11-15
CH282950A (en) 1952-05-15

Similar Documents

Publication Publication Date Title
EP1976847B1 (en) Pyrimidinyl aryl urea derivatives being fgf inhibitors
AU2005256491C1 (en) Pyrimidine urea derivatives as kinase inhibitors
JP4828421B2 (en) Quinazoline derivatives as receptor tyrosine kinase inhibitors
US2846397A (en) Water-soluble salts of derivatives of 4:4'-diaminostilbene-2:2'-disulfonic acid for enhancing the brightness of organic fibrous material
IL154514A (en) Quinazoline derivatives and pharmaceutical compositions containing the same
ATE40684T1 (en) (BENZOYL-4-PIPERIDINO)-2-PHENYL-1ALKANOL DERIVATIVES, THEIR PRODUCTION AND USE AS MEDICINES.
PT77735B (en) PROCESS FOR THE PREPARATION OF BENZOXAZOLINONE DERIVATIVES
EP0318225A2 (en) 6-Aryl aminomethyl quinoline derivatives and their use as anti-tumour agents
US2485212A (en) 2-[phenthiazinyl-(n)-methyl]-imidazolines, the corresponding 2-(phenoxazinyl) imidazolines, and their salts
SG172229A1 (en) Thiazolyl-benzimidazoles
GB664262A (en) Manufacture of heterocyclically substituted diaminoquinazolines
JP2021510704A (en) 5- (Pyrimidine-4-yl) thiazole-2-ylurea derivative as a therapeutic agent
GB832400A (en) New anthraquinonoid dyestuffs
US2248356A (en) Method of preparing aminated esters
US2488379A (en) Quinazoline derivatives
Kelarev et al. Synthesis and Properties of sym-Triazine Derivatives. 18. Synthesis of N-Substituted 2, 4-Diamino-6-(benzothiazolyl-2-thiomethyl)-sym-triazines
NZ209707A (en) Sulphenamide derivatives and pharmaceutical compositions
ES530878A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF AMINOETICPIRIDINA OR PIRAZINA.
SU1355128A3 (en) Method of producing piperazine-containing derivatives of alkylthiol or alkylthiocarbamate,or salts thereof
US2952687A (en) Certain n-
US2692881A (en) Benzothiazole derivatives
Penchev et al. Preparation of 2-(N-alkyl-N-arylamino) ethyl trimethylammonium salts
GB662798A (en) Improvements in or relating to the production of sulphonamides and intermediates thereof
PL97545B1 (en) METHOD OF MAKING NEW DERIVATIVES OF OXAZOLIDIN
GB939822A (en) Piperazine compounds